Sandra Patterson - 10 Jun 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controllership
Signature
/s/ Edward S. Son by Power of Attorney for Sandra C. Patterson
Issuer symbol
GILD
Transactions as of
10 Jun 2024
Net transactions value
-$16,639
Form type
4
Filing time
11 Jun 2024, 19:23:09 UTC
Previous filing
12 Mar 2024
Next filing
12 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +901 +2.8% 33,533 10 Jun 2024 Direct F1
transaction GILD Common Stock Tax liability $16,639 -255 -0.76% $65.25 33,278 10 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -901 -4.8% 17,762 10 Jun 2024 Common Stock 901 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.